JP6529216B2 - ハウスダストによるくしゃみ抑制用組成物 - Google Patents
ハウスダストによるくしゃみ抑制用組成物 Download PDFInfo
- Publication number
- JP6529216B2 JP6529216B2 JP2013249674A JP2013249674A JP6529216B2 JP 6529216 B2 JP6529216 B2 JP 6529216B2 JP 2013249674 A JP2013249674 A JP 2013249674A JP 2013249674 A JP2013249674 A JP 2013249674A JP 6529216 B2 JP6529216 B2 JP 6529216B2
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- allergen
- ostrich
- house dust
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000428 dust Substances 0.000 title claims description 24
- 239000000203 mixture Substances 0.000 title claims description 21
- 206010041232 sneezing Diseases 0.000 title claims description 4
- 239000013566 allergen Substances 0.000 claims description 63
- 241000272534 Struthio camelus Species 0.000 claims description 37
- 239000000427 antigen Substances 0.000 claims description 27
- 102000036639 antigens Human genes 0.000 claims description 27
- 108091007433 antigens Proteins 0.000 claims description 27
- 241000282326 Felis catus Species 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 210000002969 egg yolk Anatomy 0.000 description 31
- 235000013345 egg yolk Nutrition 0.000 description 23
- 241000287828 Gallus gallus Species 0.000 description 21
- 241000286209 Phasianidae Species 0.000 description 21
- 235000013330 chicken meat Nutrition 0.000 description 21
- 102000002322 Egg Proteins Human genes 0.000 description 17
- 108010000912 Egg Proteins Proteins 0.000 description 17
- 230000003053 immunization Effects 0.000 description 17
- 238000002965 ELISA Methods 0.000 description 14
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 11
- 102000004201 Ceramidases Human genes 0.000 description 11
- 108090000751 Ceramidases Proteins 0.000 description 11
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 11
- 229940106189 ceramide Drugs 0.000 description 11
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 11
- 238000002649 immunization Methods 0.000 description 11
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 11
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 9
- 230000009257 reactivity Effects 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 241000271566 Aves Species 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000282465 Canis Species 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 238000013207 serial dilution Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000013573 pollen allergen Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 208000035533 House dust allergy Diseases 0.000 description 1
- 206010030111 Oedema mucosal Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Description
ダニアレルゲンに対する抗体を以下のようにし作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。ダニアレルゲン(Dfb,Dpb,Dff,Dpf)50μgをフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。
ハウスダストに対する抗体を以下のようにして作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。ハウスダストアレルゲン50μgをフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。なお、ここでハウスダストアレルゲンとは、生活空間から採取されたアレルゲンと考えられる物質の集合である。
ハウスダストアレルゲンを抗原として得た卵黄抗体の効果を調べた。ハウスダストアレルゲンを染み込ませて乾燥したディスク濾紙(1ディスク中5μgのアレルゲンを含有)(商品名:アレルゲンディスク「トリイ」ハウスダスト)に5μLのPBS(リン酸緩衝液)、または5μLのダチョウ卵黄抗体(ダニアレルゲンDfbまたはハウスダストアレルゲンを免疫して作製したもの)(15mg/mL)を添加し、室温で10分間放置した。その後、ディスク濾紙をハウスダストアレルギー罹患ボランティアの下鼻甲介粘膜に付け、5分間放置し、臨床症状(鼻内掻痒感、くしゃみ、水性鼻漏、粘膜腫脹)の有無を観察し、臨床症状の症状別の発現率を算出した。結果を表3に示す。
緑膿菌ホモジネート液を抗原とした抗体を以下のように作製した。成熟したメス鳥(ダチョウ、ニワトリ、ウズラ)を用いた。緑膿菌のホモジネート液(蛋白量50μg)をフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原を接種したことになる。
Claims (2)
- ダチョウの雌の卵に由来する精製抗体であって、ハウスダストに係る複数のアレルゲンを抗原とする抗体を含むハウスダストによるくしゃみ抑制用組成物であって、前記アレルゲンがダニアレルゲン、イヌアレルゲン又はネコアレルゲンである、くしゃみ抑制用組成物。
- 請求項1に記載のハウスダストによるくしゃみ抑制用組成物を有するフィルター。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013249674A JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013249674A JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017243883A Division JP6586450B2 (ja) | 2017-12-20 | 2017-12-20 | アレルゲン抗体およびそれを有する組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015105266A JP2015105266A (ja) | 2015-06-08 |
JP6529216B2 true JP6529216B2 (ja) | 2019-06-12 |
Family
ID=53435612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013249674A Active JP6529216B2 (ja) | 2013-12-02 | 2013-12-02 | ハウスダストによるくしゃみ抑制用組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6529216B2 (ja) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0920684A (ja) * | 1995-07-07 | 1997-01-21 | Lotte Co Ltd | チューインガム |
JP5208494B2 (ja) * | 2007-12-27 | 2013-06-12 | 花王株式会社 | アレルゲン不活化剤 |
JP5850484B2 (ja) * | 2011-01-12 | 2016-02-03 | 住化エンバイロメンタルサイエンス株式会社 | 抗アレルゲン組成物 |
JP2013147471A (ja) * | 2012-01-23 | 2013-08-01 | Venture Bank Inc | ダチョウ抗体水溶液 |
JP6200630B2 (ja) * | 2012-02-10 | 2017-09-20 | オーストリッチファーマ株式会社 | 医薬組成物 |
JP5939827B2 (ja) * | 2012-02-14 | 2016-06-22 | フマキラー株式会社 | アレルゲン失活剤 |
-
2013
- 2013-12-02 JP JP2013249674A patent/JP6529216B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015105266A (ja) | 2015-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Quirce et al. | Chicken serum albumin (Gal d 5*) is a partially heat‐labile inhalant and food allergen implicated in the bird‐egg syndrome | |
Baxi et al. | The role of allergen exposure and avoidance in asthma | |
Rakhmatbaevna | Etiological factors of acute allergic conditions in children living in the conditions of the city of Bukhara | |
Strzelczyk et al. | Avoidance of allergens as an environmental method in the prevention of inhaled allergy symptoms | |
CA2798151A1 (en) | Immunogen adherence and method of making and using same | |
Luo et al. | Effect of enriched housing on levels of natural (auto-) antibodies in pigs co-infected with porcine reproductive and respiratory syndrome virus (PRRSV) and Actinobacillus pleuropneumoniae | |
JP6529216B2 (ja) | ハウスダストによるくしゃみ抑制用組成物 | |
Platts-Mills | Allergen avoidance in the treatment of asthma and allergic rhinitis | |
Kilpiö et al. | Allergy to feathers | |
KR101085540B1 (ko) | 여드름균에 대한 항체를 지닌 난황을 함유하는 여드름 개선용 화장료 조성물 | |
JP6586450B2 (ja) | アレルゲン抗体およびそれを有する組成物 | |
JP2017006008A (ja) | Mers用抗体および抗血清 | |
Giséle et al. | Prevalence of sensitization to the predatory mite Amblyseius cucumeris as a new occupational allergen in horticulture | |
Summerbell et al. | Household hyphomycetes and other indoor fungi | |
Sevcik et al. | On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production | |
CN114470198B (zh) | 一种用于防治新冠肺炎的SARS-CoV-2卵黄中和抗体IgY喷雾剂 | |
Gabanakgosi et al. | Ethnoveterinary medicine usage in family chickens in the selected four villages of Botswana | |
Ho et al. | Respiratory health in home and leisure pursuits | |
Squillace | Allergens of arthropods and birds | |
Vieira-Pires et al. | IgY industries and markets | |
Lin et al. | Novel approaches for inhibiting the indoor allergen Der f 2 excreted from house dust mites by todomatsu oil produced from woodland residues | |
Tsukamoto et al. | Ostrich antibody and its application to skin diseases, a review and case report | |
Squillace | Environmental control | |
Shehata et al. | Efficacy of cold fogging and oral herbal extracts on air quality and immune response of broilers | |
MOLINA | 10 Occupational Extrinsic Allergic Alveolitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170822 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171220 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180123 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190315 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190514 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6529216 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |